CPT 88189Laboratory

Flowcytometry/read 16 & >

CPT code 88189 covers the professional interpretation of complex flow cytometry tests that analyze 16 or more cell markers, typically used to diagnose blood cancers and immune system disorders. This is the physician work of reading and reporting the results, not the technical performance of the test itself.

Showing rates for

National Average

Base Medicare rate

$79.25

This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.

RVU breakdown

Work RVU

1.7

PE RVU (NF)

0.68

MP RVU

0.07

Total RVU

2.45

Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High

NCCI bundling edits

Loading bundling edits…

Billing tips

Precisely document the number of markers analyzed in the interpretation report—88189 requires 16 or more markers, while 88188 (9-15 markers) reimburses less
Impact: Using correct code based on marker count prevents up to 30-40% revenue loss from downcoding
Bill the professional component (modifier 26) separately unless you own both the equipment and employ the technical staff
Impact: Prevents claim denials; the $79.25 rate typically represents the global fee, split between TC and professional components
Link to specific ICD-10 codes for hematologic malignancies (C91.x, C92.x, D89.x) rather than generic screening codes to establish medical necessity
Impact: Reduces denial rate by 15-25% by meeting LCD coverage criteria for flow cytometry panels
Maintain a detailed marker list in the interpretation report documenting all antibodies/markers used and their clinical relevance
Impact: Critical for audit defense; marker documentation is the primary element reviewed in post-payment audits
Do not bill 88189 with 88184-88187 on the same specimen—these are tiered codes based on marker count
Impact: Prevents automatic denials for code bundling; only one flow cytometry interpretation code per specimen
Verify LCD requirements for ABN (Advanced Beneficiary Notice) if ordering for non-covered indications like routine screening
Impact: Protects against beneficiary complaints and collection issues when Medicare denies payment

Common denials

Live Field Datano reports yet

Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.

Working with CPT 88189?

Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.

Help build the field knowledge

MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.

Related actions

Frequently asked questions

What is the difference between CPT 88189 and 88188?

CPT 88189 is used for flow cytometry interpretation with 16 or more markers, while 88188 covers 9-15 markers. The number of cell surface or intracellular markers analyzed determines which code to use. 88189 has higher work RVUs (1.7 vs 1.25) reflecting the additional complexity of interpreting larger marker panels.

How much does Medicare pay for CPT code 88189 in 2025?

The 2025 Medicare national average reimbursement for CPT 88189 is $79.25 for both facility and non-facility settings. This is based on 2.45 total RVUs (1.7 work RVU, 0.68 PE RVU, 0.07 MP RVU) multiplied by the 2025 conversion factor of 32.3465.

Can CPT 88189 be billed with modifier 26?

Yes, modifier 26 is commonly used with 88189 when billing only the professional component (physician interpretation) separately from the technical component. This is typical when a pathologist interprets flow cytometry performed at a different facility or when hospital-based pathologists bill their interpretation separately from the hospital's technical charges.

What diagnoses support medical necessity for CPT 88189?

Common supporting diagnoses include acute and chronic leukemias (C91.x, C92.x), lymphomas (C82.x-C85.x), myelodysplastic syndromes (D46.x), immunodeficiencies (D80.x-D84.x), post-transplant monitoring (Z94.81), and suspected minimal residual disease. Routine screening or non-specific symptoms typically do not meet medical necessity criteria.

How many markers are required to bill CPT 88189?

CPT 88189 requires interpretation of 16 or more cell markers. Each marker (antibody/antigen combination) must be documented in the interpretation report. If fewer than 16 markers are used, a lower-level code (88184-88188) should be billed instead based on the actual marker count.

Can I bill multiple units of CPT 88189 for the same patient on the same day?

Multiple units may be appropriate only if analyzing truly distinct specimens (e.g., bone marrow and lymph node) or performing separate analyses for different clinical questions. Use modifier 59 or 91 to indicate distinct services and document the medical necessity for multiple interpretations. Same specimen analyzed with different marker panels typically counts as one comprehensive interpretation.

What is the work RVU for CPT code 88189?

The 2025 work RVU for CPT 88189 is 1.7, with practice expense RVU of 0.68 and malpractice RVU of 0.07, totaling 2.45 RVUs. This reflects the physician work involved in interpreting complex multi-parameter flow cytometry data with 16 or more markers.